敗血症性ショックにおけるレニン-アンジオテンシン系の機能不全 (MANTRA)
Despite best therapy efforts, sepsis and septic shock are associated with mortality rates of up to 40%. This clinical trial will determine the benefit of exogenous Angiotensin II versus norepinephrine (conventional care) treatment in septic shock patients. This trial will determine whether there are better predictors of septic shock severity. This approach may inform more appropriate treatment regimens and improve outcomes for these patients.
調査の概要
詳細な説明
This study will determine whether normalization of renin-angiotensin-aldosterone system (RAAS) signaling in sepsis occurs more rapidly with treatment with Angiotensin II compared with conventional vasopressors. Trial samples will be used to identify the best RAAS biomarker predictor of treatment response via in-depth longitudinal analysis of RAAS component and to determine the extent and mechanisms of Angiotensin II impact on innate immune function during sepsis. Successful accomplishment of our aims will provide the capability to improve endotyping of septic patients by establishing the most precise and robust measurement of renin (and RAAS dysfunction). This work will improve staging and clinical precision and will facilitate the criteria for therapeutic development of targets in septic shock.
研究の種類
入学 (推定)
段階
- フェーズ 4
連絡先と場所
研究連絡先
- 名前:Ashish Khanna, MD
- 電話番号:513-658-5866
- メール:ashish.khanna@wfusm.edu
研究連絡先のバックアップ
- 名前:Lynnette Harris, RN
- 電話番号:336-716-8791
- メール:lynnette.harris@advocatehealth.org
研究場所
-
-
Massachusetts
-
Boston、Massachusetts、アメリカ、02114
- Massachusetts General Hospital-Harvard
-
コンタクト:
- Michael R Filbin, MD, MS
- メール:mfilbin@mgh.harvard.edu
-
コンタクト:
- Daniel E Leisman, MD
- メール:dleisman@mgh.harvard.edu
-
主任研究者:
- Michael R Filbin, MD, MS
-
主任研究者:
- Daniel E Leisman, MD
-
副調査官:
- Marcia Goldberg, MD
-
副調査官:
- Kathryn Hibbert, MD
-
-
North Carolina
-
Winston-Salem、North Carolina、アメリカ、27157
- Atrium Health Wake Forest Baptist
-
コンタクト:
- Lynnette C Harris, BSN
- 電話番号:336-716-8791
- メール:lcharris@wakehealth.edu
-
コンタクト:
- Ashish Khanna, MD
- 電話番号:513-658-5866
- メール:akhanna@wakehealth.edu
-
主任研究者:
- Ashish Khanna, MD
-
副調査官:
- Christopher Schaich, PhD
-
副調査官:
- Daniel C Files, MD
-
主任研究者:
- Mark Chappell, PhD
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- The presence of septic shock, defined by sepsis-3 criteria: 1-adult patients (18 years or older) with septic shock, defined by SEPSIS-3 criteria: a) suspected or known infection, b) hypotension requiring vasopressors, and c) lactate >2mmol/L 2-receiving either norepinephrine or phenylephrine with or without additional vasopressor support 3- total norepinephrine equivalent dose (NED) ≥0.1 mcg/kg/min and ≤0.5 mcg/kg/min, to maintain a MAP of at least 65 mmHg, is required for randomization 4-ability to consent and randomize within 24 hrs of first reaching NED threshold and within 48 hrs of hospital arrival
Exclusion Criteria:
- Age <18 years
- Prisoners
- Pregnant women
- Patients for whom urgent surgery is anticipated
- Leukocyte count <1,000 cells/μL
- Absolute monocyte count <200 cells/μL
- Bone marrow transplant within the past 30 days
- Patients that will be withdrawing aggressive resuscitation, including withdraw of vasopressor support
- transfer from outside ICU
- history of liver cirrhosis with Child-Pugh score ≥6
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Angiotensin II
Continuous infusion of Angiotensin II for up to 48 hours |
randomized to receive Angiotensin II continuous infusion for up to 48 hours |
|
アクティブコンパレータ:Norepinephrine
Continuous infusion of Norepinephrine for up to 48 hours |
randomized to receive Norepinephrine continuous infusion for up to 48 hours |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Mean Renin Level - Hour 24
時間枠:Hour 24
|
Mean plasma renin level (PRA) as a measure of renin-angiotensin-aldosterone system restoration. Normal levels of active renin <1.1 pM (40 pg/mL). A level higher than normal can indicate level of shock. |
Hour 24
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Norepinephrine Equivalent Dose Requirement (NEE)
時間枠:Baseline, Hour 3, Hour 12, Hour 24, Hour 48, Hour 72
|
NEE indicates severity of shock and need for vasopressors to support blood pressure. Normal range is 0.0-1.0 mcg/kg/min. Levels above normal indicate shock and need for vasopressors. The higher the level the more severe. |
Baseline, Hour 3, Hour 12, Hour 24, Hour 48, Hour 72
|
|
Number of Days Without Renal Replacement Therapy
時間枠:Day 28
|
Number of days without renal replacement therapy |
Day 28
|
|
Number of Days of Vasopressor Use
時間枠:Day 28
|
Number of days without vasopressor use |
Day 28
|
|
Number of Days Without Mechanical Ventilation
時間枠:Day 28
|
Number of days without invasive mechanical ventilation |
Day 28
|
|
Number of Hours Vasopressor Free
時間枠:Hour 72
|
Number of hours without requiring vasopressors during first 72 hours after randomization |
Hour 72
|
|
Number of Hours Alive
時間枠:Hour 72
|
Number of hours alive during first 72 hours after randomization |
Hour 72
|
|
Number of Days Alive
時間枠:Day 28
|
Number of days alive |
Day 28
|
|
Mean Renin Level
時間枠:Baseline, Hour 3, Hour 12, Hour 48, Hour 72
|
Mean renin level as a measure of renin-angiotensin-aldosterone system restoration. Normal levels of active renin <1.1 pM (40 pg/mL). A level higher than normal can indicate level of shock. |
Baseline, Hour 3, Hour 12, Hour 48, Hour 72
|
|
Sequential Organ Failure Assessment (SOFA) Score
時間枠:Baseline, Hour 24, Hour 48
|
SOFA score indicates the number and severity of failed organs and provides prognostic information on in-hospital survival in patients with severe sepsis and septic shock. Score above 0 indicates organ failure. The higher the score the more failed organs and degree of organ failure. |
Baseline, Hour 24, Hour 48
|
|
APACHE-II Score
時間枠:Baseline, Hour 24, Hour 48
|
APACHE-II score assesses severity of illness in critically ill patients and indicates risk of mortality. Score range 0-10 low risk of mortality, 11-20 moderate risk, 21-30 high risk, 31 or above very high risk. |
Baseline, Hour 24, Hour 48
|
|
Lactate Level
時間枠:Baseline, Hour 3, Hour 12, Hour 24, Hour 48, Hour 72
|
Lactate is an indicator of sepsis severity. Levels 2.3-20 mmol/L indicate sepsis. The higher the score the more severe. |
Baseline, Hour 3, Hour 12, Hour 24, Hour 48, Hour 72
|
|
Kidney Disease Improving Global Outcomes (KDIGO) Stage
時間枠:Baseline, Hour 24, Hour 48
|
Participant stage of acute kidney injury will be determined as follows Stage 1: Increase in serum creatinine ≥ 0.3 mg/dL in 48 hours or 1.5 to 1.9 multiplied by baseline (in 7 days); Stage 2: 2.0 to 2.9 multiplied by baseline serum creatinine; Stage 3: 3.0 or more multiplied by baseline; increase in serum creatinine ≥ 4.0 mg/dL; or beginning of renal replacement therapy regardless of a previous KDIGO stage. Higher stage indicates higher severity of renal failure. |
Baseline, Hour 24, Hour 48
|
|
Creatinine Level
時間枠:Baseline, Hour 24, Hour 48
|
Creatinine level is an indicator of renal disease severity. Normal range for women 0.7-1.3 mg/dL, men 0.6-1.1 mg/dL. Levels higher than normal indicate renal disease. The higher the level the more severe. |
Baseline, Hour 24, Hour 48
|
|
BUN Level
時間枠:Baseline, Hour 24, Hour 48
|
BUN level is an indicator of renal disease severity. Levels above 24 mg/dL indicate renal disease. The higher the level the more severe. |
Baseline, Hour 24, Hour 48
|
|
Bicarbonate Level
時間枠:Baseline, Hour 24, Hour 48
|
Bicarbonate level is an indicator of acid base disturbance severity. Normal range is 22-29 mEq/L. Levels above or below the normal range indicate acid base disturbance. The higher the score the more severe. |
Baseline, Hour 24, Hour 48
|
|
Number of Participants with Acute Respiratory Distress Syndrome (ARDS)
時間枠:Baseline, Hour 24, Hour 48
|
Number of participants with ARDS |
Baseline, Hour 24, Hour 48
|
|
SpO2/FiO2 Ratio Level
時間枠:Baseline, Hour 24, Hour 48
|
SpO2/FiO2 ratio level is an indicator of lung injury severity. Mild severity 315-235, moderate severity 148-235, severe <148. |
Baseline, Hour 24, Hour 48
|
|
PaO2/FiO2 Ratio Level
時間枠:Baseline, Hour 24, Hour 48
|
PaO2/FiO2 ratio level is an indicator of lung injury severity. Mild severity 201-300 mmHg; moderate severity 101-200 mmHg, severe ≤ 100 mmHg. |
Baseline, Hour 24, Hour 48
|
|
Serum Aspartate Aminotransferases Level
時間枠:Baseline, Hour 24, Hour 48
|
Serum aspartate aminotransferases level is an indicator of liver injury severity. Normal range 8-48 U/L. Levels above normal indicate livery injury. The higher the level the more severe. |
Baseline, Hour 24, Hour 48
|
|
Alanine Aminotransferases Level
時間枠:Baseline, Hour 24, Hour 48
|
Alanine aminotransferases level is indicator of liver injury severity. Normal range 7-55 U/L. Levels higher than normal indicate liver injury. The higher the level the more severe. |
Baseline, Hour 24, Hour 48
|
|
Alkaline Phosphatase Level
時間枠:Baseline, Hour 24, Hour 48
|
Alkaline phosphatase level is an indicator of liver injury severity. Normal range 40-129 U/L. Levels higher than normal indicate liver injury. The higher the level the more severe. |
Baseline, Hour 24, Hour 48
|
|
Bilirubin Level
時間枠:Baseline, Hour 24, Hour 48
|
Bilirubin level is an indicator of liver injury severity. Normal range 0.1-1.2 mg/dL. Levels higher than normal indicate liver injury. The higher the liver the more severe. |
Baseline, Hour 24, Hour 48
|
|
Albumin Level
時間枠:Baseline, Hour 24, Hour 48
|
Albumin level is an indicator of liver injury severity. Normal range 3.5-5.0 g/dL. Levels higher than normal indicate liver injury. The higher the level the more severe. |
Baseline, Hour 24, Hour 48
|
|
Troponin I Level
時間枠:Baseline, Hour 24, Hour 48
|
Troponin I level is an indicator of cardiac myocyte injury. Normal range 0-0.04 ng/mL. Levels higher than normal indicate cardiac myocyte injury. The higher the level the more severe. |
Baseline, Hour 24, Hour 48
|
|
Troponin T Level
時間枠:Baseline, Hour 24, Hour 48
|
Troponin T level is an indicator of cardiac myocyte injury. Normal range 0-0.01 ng/mL. Levels higher than normal indicate cardiac myocyte injury. The higher the level the more severe. |
Baseline, Hour 24, Hour 48
|
|
Neutrophil Gelatinase-Associated Lipocalin Serum Level
時間枠:Baseline, Hour 24, Hour 48
|
Neutrophil gelatinase-associated lipocalin serum level indicates risk of kidney injury. Normal serum level is <10 mcg/L. Levels higher than normal indicate risk of kidney injury. |
Baseline, Hour 24, Hour 48
|
|
Neutrophil Gelatinase-Associated Lipocalin Urine Level
時間枠:Baseline, Hour 24, Hour 48
|
Neutrophil gelatinase-associated lipocalin urine level indicates risk of kidney injury. Normal urine level is ≤50 ng/ml. Risk of kidney disease: Low risk 51-149 ng/ml, moderate risk 150-299 ng/ml, and high risk ≥300 ng/ml. |
Baseline, Hour 24, Hour 48
|
|
Kidney Injury Molecule-I Urine Level
時間枠:Baseline, Hour 24, Hour 48
|
Kidney injury molecule-I urine level is used to detect kidney injury. Normal level is <1 ng/ml. Levels higher than normal indicate ischemic kidney injury. |
Baseline, Hour 24, Hour 48
|
|
Kidney Injury Molecule-I Blood Level
時間枠:Baseline, Hour 24, Hour 48
|
Kidney injury molecule-I blood level is used to detect kidney injury. Normal levels 0.42-2.0 ng/ml. Levels higher than normal indicate kidney injury. The higher the level the more severe. |
Baseline, Hour 24, Hour 48
|
|
Soluble Receptor for Advanced Glycation End Product Level
時間枠:Baseline, Hour 24, Hour 48
|
Soluble receptor for advanced glycation end product level is a marker of aging, hypertension and diabetes. Normal range is 647-1248 pg/ml. Levels higher than normal indicate risk for hypertension and diabetes. |
Baseline, Hour 24, Hour 48
|
|
Angiopoietin-2 Level
時間枠:Baseline, Hour 24, Hour 48, Hour 72
|
Angiopoietin-2 level is a marker of inflammation. Normal range is 1434-4141 pg/mL. Levels higher than normal indicate inflammation. |
Baseline, Hour 24, Hour 48, Hour 72
|
|
Syndecan-1 Level
時間枠:Baseline, Hour 24, Hour 48
|
Syndecan-1 level is a marker of disease severity in critically ill patients. Levels >20ng/ml indicate severe disease. The higher the level the more severe. |
Baseline, Hour 24, Hour 48
|
|
Protein C Level
時間枠:Baseline, Hour 24, Hour 48
|
Protein C level is an indicator of inflammation and thrombotic state. Normal level is <8 mg/L. Levels higher than normal indicate inflammation and thrombotic state. The higher the level the more severe. |
Baseline, Hour 24, Hour 48
|
|
Neuron-Specific Enolase Level
時間枠:Baseline, Hour 24, Hour 48
|
Neuron-specific enolase level is an indicator of brain injury. Normal range is 16-17 ug/L. Levels higher than normal indicate brain injury. The higher the level the more severe. |
Baseline, Hour 24, Hour 48
|
|
S-100β Level
時間枠:Baseline, Hour 24, Hour 48
|
S-100β level is indicator of brain injury. Normal range is 0.02-0.05 μg/dL. Levels higher than normal indicate brain injury. The higher the number the more severe. |
Baseline, Hour 24, Hour 48
|
|
TNFα Level
時間枠:Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
TNFα level is an indicator of systemic inflammation. Normal levels are 75 +/- 15 pg/ml. Levels higher than normal indicate inflammation. The higher the score the more severe. |
Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
|
sTNFR1 Level
時間枠:Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
sTNFR1 level is an indicator of systemic inflammation. Normal levels are <2.4 ng/ml. Levels higher than normal indicate inflammation. The higher the score the more severe. |
Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
|
IL-6 Level
時間枠:Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
IL-6 level is an indicator of systemic inflammation. Normal range is 0-43.5 pg/ml. Levels higher than normal indicate inflammation. The higher the score the more severe. |
Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
|
sIL-6R Level
時間枠:Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
sIL-6R level is an indicator of systemic inflammation. Normal range is 14-46 pg/ml. Levels higher than normal indicate inflammation. The higher the score the more severe. |
Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
|
IL-8 Level
時間枠:Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
IL-8 level is an indicator of systemic inflammation. Normal range is 0-66.1 pg/ml. Levels higher than normal indicate inflammation. The higher the score the more severe. |
Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
|
IL-1β Level
時間枠:Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
IL-1β level is an indicator of systemic inflammation. Normal range is 0.5-12 pg/ml. Levels higher than normal indicate inflammation. The higher the score the more severe. |
Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
|
Interferon Gamma Level
時間枠:Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
IFN-ɣ level is an indicator of systemic inflammation. Normal range is 0-8.6 pg/ml. Levels higher than normal indicate inflammation. The higher the score the more severe. |
Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
|
IL12p70 Level
時間枠:Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
IL12p70 level is an indicator of systemic inflammation. Normal range is 0-1.9 pg/ml. Levels higher than normal indicate inflammation. The higher the score the more severe. |
Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
|
IL-17 Level
時間枠:Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
IL-17 level is an indicator of systemic inflammation. Normal range is 0-1.4 pg/ml. Levels higher than normal indicate inflammation. The higher the score the more severe. |
Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
|
MIP1-alpha Level
時間枠:Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
MIP1-αlpha level is an indicator of systemic inflammation. Normal range is 0-208 pg/ml. Levels higher than normal indicate inflammation. The higher the score the more severe. |
Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
|
MIP1-beta Level
時間枠:Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
MIP1-beta level is an indicator of systemic inflammation. Normal range is 59-647 pg/ml. Levels higher than normal indicate inflammation. The higher the score the more severe. |
Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
|
IP-10 Level
時間枠:Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
IP-10 level is an indicator of systemic inflammation. Normal range is 4.8-9.8 pg/ml. Levels higher than normal indicate inflammation. The higher the score the more severe. |
Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
|
IL-10 Level
時間枠:Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
IL-10 level is an indicator of systemic inflammation. Normal range is 4.8-9.8 pg/ml. Levels higher than normal indicate inflammation. The higher the score the more severe. |
Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
|
IL-1RA Level
時間枠:Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
IL-1RA level is an indicator of systemic inflammation. Normal range is 100-300 ng/ml. Levels higher than normal indicate inflammation. The higher the score the more severe. |
Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
|
IL-12p40 Level
時間枠:Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
IL-12p40 level is an indicator of systemic inflammation. Normal range is 0.064-1000 pg/ml. Levels higher than normal indicate inflammation. The higher the score the more severe. |
Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
|
C reactive protein (CRP) Level
時間枠:Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
CRP level is an indicator of systemic inflammation. Normal range is 0-10 mg/dl. Levels higher than normal indicate inflammation. The higher the score the more severe. |
Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
|
Procalcitonin Level
時間枠:Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
Procalcitonin level is an indicator of systemic inflammation. Levels >0.25 mg/ml indicate inflammation and infection. The higher the score the more severe. |
Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
|
Platelet Level
時間枠:Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
Platelet level is an indicator of systemic inflammation and thrombocytosis. Normal range is 150000-450000 platelets per microliter. Levels higher than normal indicate inflammation and thrombocytosis. The higher the score the more severe. |
Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
|
Absolute Neutrophil Count Level
時間枠:Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
Absolute neutrophil count level is an indicator of inflammation and infection/sepsis. Normal range is 2500-7000 neutrophils per microliter. Levels higher than normal indicate inflammation, infection/sepsis. The higher the score the more severe. |
Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
|
Absolute Granulocyte Count Level
時間枠:Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
Absolute granulocyte count level is an indicator of inflammation and infection/sepsis. Normal range is 1500-8500 granulocytes per microliter. Levels higher than normal indicate inflammation, infection/sepsis. The higher the score the more severe. |
Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
|
Absolute Lymphocytes Count Level
時間枠:Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
Absolute lymphocyte count level is an indicator of inflammation and infection/sepsis. Normal range is 1000-4800 granulocytes per microliter. Levels higher than normal indicate inflammation, infection/sepsis. The higher the score the more severe. |
Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
|
Neutrophil-Lymphocyte Ratio Level
時間枠:Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
Neutrophil-lymphocyte ratio level is an indicator of inflammation and infection/sepsis or marrow malignancy. Normal range is 1-2. Levels higher than normal indicate inflammation, infection/sepsis, marrow malignancy. The higher the score the more severe. |
Baseline, Hour 3, Hour 12, Hour 24, Hour 48
|
|
Angiotensin (1-7)
時間枠:Baseline, Hour 3, Hour 12, Hour 24, Hour 48, Hour 72
|
Angiotensin (1-7) level as a measure of the renin-angiotensin-aldosterone system |
Baseline, Hour 3, Hour 12, Hour 24, Hour 48, Hour 72
|
|
Plasma renin activity
時間枠:baseline, hour 3, hour 12, hour 24, hour 48
|
levels at indicated timepoints |
baseline, hour 3, hour 12, hour 24, hour 48
|
|
Prorenin
時間枠:baseline, hour 3, hour 12, hour 24, hour 48
|
levels at indicated timepoints |
baseline, hour 3, hour 12, hour 24, hour 48
|
|
Soluble prorenin receptor (sPRR)
時間枠:baseline, hour 24, hour 48
|
levels at indicated timepoints |
baseline, hour 24, hour 48
|
|
Aldosterone
時間枠:baseline, hour 3, hour 12, hour 24, hour 48
|
levels at indicated timepoints |
baseline, hour 3, hour 12, hour 24, hour 48
|
|
Intact Aogen
時間枠:baseline, hour 24, hour 48
|
levels at indicated timepoints |
baseline, hour 24, hour 48
|
|
ANG II
時間枠:baseline, hour 3, hour 12, hour 24, hour 48, hour 72
|
levels at indicated timepoints |
baseline, hour 3, hour 12, hour 24, hour 48, hour 72
|
|
Angiotensin-converting enzyme (ACE)
時間枠:baseline, hour 24, hour 48
|
levels at indicated timepoints |
baseline, hour 24, hour 48
|
|
Angiotensin-converting enzyme-2 (ACE2)
時間枠:baseline, hour 24, hour 48
|
levels at indicated timepoints |
baseline, hour 24, hour 48
|
|
Dipeptidyl peptidase 3 (DPP3)
時間枠:baseline, hour 24, hour 48
|
levels at indicated timepoints |
baseline, hour 24, hour 48
|
|
RNA Paxgene Bulk (Bulk RNA sequencing)
時間枠:baseline, hour 24, hour 48
|
levels at indicated timepoints |
baseline, hour 24, hour 48
|
|
Whole blood cryopreserved (scRNAsesq)
時間枠:baseline, hour 24, hour 48
|
levels at indicated timepoints |
baseline, hour 24, hour 48
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Patients with New Deep Venous Thrombosis
時間枠:Day 7, Day 28
|
Number of patients with development of new deep venous thrombosis |
Day 7, Day 28
|
|
Patients with New Pulmonary Embolism
時間枠:Day 7, Day 28
|
Number of patients with development of new pulmonary embolism |
Day 7, Day 28
|
|
Patients with New-Onset Atrial Fibrillation
時間枠:Hour 72, day 28
|
Number of patients with new-onset atrial fibrillation |
Hour 72, day 28
|
|
Patients with New-Onset Ventricular Arrhythmias
時間枠:Hour 72, Day 7, Day 28
|
Number of patients with new-onset ventricular arrhythmias |
Hour 72, Day 7, Day 28
|
協力者と研究者
捜査官
- 主任研究者:Ashish Khanna, MD、Atrium Health Wake Forest Baptist
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
- 泌尿生殖器疾患
- 病理学的プロセス
- 男性の泌尿生殖器疾患
- 泌尿器疾患
- 女性の泌尿生殖器疾患
- 女性の泌尿生殖器疾患と妊娠合併症
- 感染症
- 全身性炎症反応症候群
- 炎症
- ショック
- 病理学的状態、徴候および症状
- 敗血症
- 腎臓病
- ショック、敗血症
- ホルモン
- ホルモン、ホルモン代替品、ホルモン拮抗薬
- ペプチドホルモン
- 神経ペプチド
- ペプチド
- アミノ酸、ペプチド、およびタンパク質
- オリゴペプチド
- 神経組織タンパク質
- タンパク質
- 有機化学物質
- 炭化水素
- 炭化水素、周期的
- 生物学的要因
- 炭化水素、芳香
- アミン
- カテコール
- フェノール
- ベンゼン誘導体
- アルコール
- アミノアルコール
- エタノールアミン
- オアコイド
- 炎症メディエーター
- 生体モノアミン
- 生体アミン
- カテコールアミン
- アンジオテンシン
- ノルアドレナリン
- アンジオテンシン II
その他の研究ID番号
- IRB00115287
- R01HL177834 (米国 NIH グラント/契約)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
米国で製造され、米国から輸出された製品。
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。